D. Abushanab

发表

The Economic Impact of Optimizing a COVID-19 Management Protocol in Pre-Existing Cardiovascular Disease Patients

S. Doi, D. Al-Badriyeh, S. Al-Máadeed, 2022, Current Problems in Cardiology.

Cost-effectiveness analysis of sacubitril/valsartan for reducing the use of implantable cardioverter-defibrillator (ICD) and the risk of death in ICD-eligible heart failure patients with reduced ejection fraction.

D. Abushanab, D. Al-Badriyeh, A. Arabi, 2022, Current problems in cardiology.

Future burden of cardiovascular disease in Australia: impact on health and economic outcomes between 2020 and 2029.

Z. Ademi, D. Liew, D. Abushanab, 2021, European journal of preventive cardiology.

Projecting the Health and Economic Burden of Cardiovascular Disease Among People with Type 2 Diabetes, 2022–2031

Z. Ademi, D. Magliano, D. Abushanab, 2023, PharmacoEconomics.

Cost-Effectiveness Analysis of Out-Of-Hospital versus In-Hospital Extracorporeal Cardiopulmonary Resuscitation for Out-Hospital Refractory Cardiac Arrest.

D. Abushanab, D. Al-Badriyeh, A. A. Hssain, 2022, Current problems in cardiology.

Prophylactic Sildenafil in Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Pilot Randomized, Double-Blinded, Placebo-Controlled Trial

D. Abushanab, D. Al-Badriyeh, A. Mansour, 2019, Clinical Drug Investigation.

A Systematic Review of Cost-Effectiveness of Non-Statin Lipid-Lowering Drugs for Primary and Secondary Prevention of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus.

Z. Ademi, D. Liew, D. Abushanab, 2022, Current problems in cardiology.

Attainment of low-density lipoprotein cholesterol goals in patients treated with combination therapy: A retrospective cohort study in primary care.

Z. Ademi, R. Ofori-Asenso, R. Wolfe, 2022, Journal of clinical lipidology.

Percutaneous Mitral Valve Repair for Secondary Mitral Regurgitation: A Systematic Review and Meta-Analysis.

R. Kaddoura, M. Al-Hijji, D. Abushanab, 2023, The American journal of cardiology.

Percutaneous mitral-valve intervention for secondary mitral regurgitation: data from real-life.

D. Al-Badriyeh, R. Kaddoura, M. Al-Hijji, 2023, Current problems in cardiology.

Comparative efficacy and safety among high-intensity statins. Systematic Review and Meta-Analysis.

D. Abushanab, D. Al-Badriyeh, M. Jaam, 2023, Journal of comparative effectiveness research.

Characteristics of the clinical pharmacists' interventions at the main general tertiary care hospital in Qatar

D. Al-Badriyeh, M. A. Hail, Mounir Atchan, 2023, Qatar Medical Journal.

Caffeine for the Treatment of Apnea in the Neonatal Intensive Care Unit: A Systematic Overview of Meta-Analyses

D. Abushanab, D. Al-Badriyeh, S. Al-Shaibi, 2020, Pediatric Drugs.

Beta-blocker therapy in heart failure with preserved ejection fraction (B-HFpEF): a systematic review and meta-analysis.

V. Madurasinghe, D. Abushanab, Dr. Rasha Kaddoura, 2024, Current problems in cardiology.

Cost-Effectiveness of Empagliflozin and Metformin Combination Versus Standard Care as First-Line Therapy in Patients with Type 2 Diabetes Mellitus.

Z. Ademi, D. Liew, D. Abushanab, 2021, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Reply to Fawad et al. Comment on: "Cost-Effectiveness Analysis of Ibuprofen versus Indomethacin or Paracetamol for the Treatment of Patent Ductus Arteriosus in Preterm Neonates" by Al-shaibi et al.

A. Awaisu, S. Al-Shaibi, Fouad F. Abounahia, 2023, Current problems in cardiology.

Use of ibuprofen for the closure of patent ductus arteriosus in preterm infants: a systematic review of meta-analyses.

D. Abushanab, D. Al-Badriyeh, R. Kaddoura, 2021, Journal of comparative effectiveness research.

Cost‑effectiveness of add‑on dapagliflozin for heart failure with reduced ejection fraction patients without diabetes.

R. Kaddoura, M. Al Hail, Salma Chbib, 2024, Journal of medical economics.

Efficacy and safety of selinexor for patients with relapsed and refractory multiple myeloma: A meta-analysis.

D. Al-Badriyeh, D. Abushanab, Laila Shafei, 2024, Current problems in cancer.

Projected New-Onset Cardiovascular Disease by Socioeconomic Group in Australia

Z. Ademi, D. Liew, D. Abushanab, 2022, PharmacoEconomics.

Societal health and economic burden of cardiovascular diseases in the population with type 2 diabetes in Qatar. A 10‐year forecasting model

Z. Ademi, D. Al-Badriyeh, C. Marquina, 2023, Diabetes, obesity & metabolism.